CN Patent

CN110831597A — 肝细胞癌的治疗

Assigned to Sanitary Material R&d Management Co ltd · Expires 2020-02-21 · 6y expired

What this patent protects

本披露提供了用于用乐伐替尼或其药学上可接受的盐治疗肝细胞癌(例如，不可切除的HCC)的方法。本披露还涵盖乐伐替尼或其药学上可接受的盐的本文所述的剂量方案，用于在根据本文所述的任一种方法治疗肝细胞癌(例如，不可切除的肝细胞癌)中使用。还披露了特别有用的剂量和发生一个或多个不良事件时的剂量修改。

USPTO Abstract

本披露提供了用于用乐伐替尼或其药学上可接受的盐治疗肝细胞癌(例如，不可切除的HCC)的方法。本披露还涵盖乐伐替尼或其药学上可接受的盐的本文所述的剂量方案，用于在根据本文所述的任一种方法治疗肝细胞癌(例如，不可切除的肝细胞癌)中使用。还披露了特别有用的剂量和发生一个或多个不良事件时的剂量修改。

Drugs covered by this patent

Patent Metadata

Patent number
CN110831597A
Jurisdiction
CN
Classification
—
Expires
2020-02-21
Drug substance claim
No
Drug product claim
No
Assignee
Sanitary Material R&d Management Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.